Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrm syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Data acquisition and processing were carried out using MassLynx version 4.1 (Waters Corp., Milford, MA, USA)
In doing so, GLP-1 RAs stimulate insulin release while suppressing glucagon secretion and slowing gastric emptying, ultimately reducing appetite
Neither compound should be understood as a proven anti-aging or general fat-loss agent, and both are prohibited in sport by the World Anti-Doping Agency (WADA)
If your prescription specifically said "semaglutide only" and you got something red, that's worth a phone call to confirm
Another key step is to recalculate your calorie needs